Delivery Order SPE2DR25D1100-SPE2DR26FCU7X
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,467.27 to AmerisourceBergen Drug Corp for the supply of Eucrisa 2% Ointment (60gm) on December 2, 2025, with completion required by December 3, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contractor's corporate office location in Conshohocken, Pennsylvania also serves...
- The Defense Logistics Agency awarded a delivery order valued at $1,956.74 to AmerisourceBergen Drug Corp for Eucrisa 2% Ointment (60gm), with an ultimate completion date of November 10, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,222.76 to AmerisourceBergen Drug Corp for the supply of Eucrisa 2% Ointment in 60-gram units. The contract was competitively awarded without set-aside provisions and carries a firm fixed price structure with a completion deadline of December 2, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a single...
- The Defense Logistics Agency awarded a delivery order valued at $1,657.85 to AmerisourceBergen Drug Corp for Eucrisa 2% Ointment (60 grams) on November 5, 2025, with completion targeted for November 6, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Eucrisa 2% Ointment in 60-gram units, with a ceiling value of $1,217.66 and an ultimate completion date of December 10, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,670.68 to AmerisourceBergen Drug Corp for the supply of Eucrisa 2% Ointment (60 grams), a topical medication commonly used for dermatological treatments. This non-competitive delivery order, issued on October 31, 2025, represents a firm fixed-price transaction with an ultimate completion date of November 3, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award falls...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Eucrisa 2% Ointment in 60-gram quantities, with a ceiling value of $1,688.16. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 18, 2025. The delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $4,275.96 delivery order to AmerisourceBergen Drug Corp for EUCRISA 2% Ointment (60GM) on December 2, 2025, with completion scheduled for December 3, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in Conshohocken, PA 19428. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $2,227.91 to AmerisourceBergen Drug Corp for EUCRISA 2% Ointment in 60-gram units. This firm fixed-price, non-set-aside contract was awarded on December 11, 2025, with an ultimate completion date of December 12, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency (DLA) awarded a $4,777.97 delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of Eucrisa 2% ointment, a topical medication. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which provides a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCU7XDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $4,062.12 to supply Eucrisa 2% Ointment (60 grams) with an ultimate completion date of December 16, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken. This delivery order represents a child action under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's established track record of competitive federal awards and its significant contract portfolio with DLA underscore its role as a critical vendor for federal medical procurement, particularly serving the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 12/14/25 |